Comparison of Continuation Rates
This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion...
Brief Summary
Official Title: “A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.”
This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.
- Study Type: Observational
- Study Design: Additional Descriptors: Convenience Sample, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective
Detailed Clinical Trial Description
Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Age 13-45 presents at the ambulatory surgery at Grady Memorial Hospital Want to use either oral contraceptive pills, ortho evra or depo provera?
Exclusion Criteria:
- Leaving the Atlanta area within 6 months? Desires pregnancy within the next 6 months?
- Unable to provide contact information? contraindications to hormonal contraceptive.
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 45 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: Emory University Other
Overall Clinical Trial Officials and Contacts
Carrie Cwiak, MD, MPH Principal Investigator Emory University
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00253019
Study ID Number: 518-2003
ClinicalTrials.gov Identifier: NCT00253019
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00253019
